About the author

avatar

Vikas Shukla

Vikas is a reporter and value investor with more than four years of investing experience. He contributes breaking news and Op-Ed columns about technology and politics on ValueWalk. Vikas spends most of his time reading investment books, writing about finance and looking for stocks that have significant growth potential.

  • John Smith

    1.4 billion insulin syringes are used each year in the u.s. alone. If one billion switch and the cost per use is say 3.50 then this makes sense. But this will be a global product and by 2025 and cases of diabetes will have increased substantially. The U.S. Only makes up 8% of diabetes world wide. Therefore I think the estimates may be low for the true potential.

Copyright © 2014 Valuewalk.com

Developed by Wordpress Junction

Share with your friends










Submit
Share with your friends










Submit